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Abstract The great demand for long-wavelength and high signal-to-noise Ca2+ indicators has led
us to develop CaRuby-Nano, a new functionalizable red calcium indicator with nanomolar affinity for
use in cell biology and neuroscience research. In addition, we generated CaRuby-Nano dextran
conjugates and an AM-ester variant for bulk loading of tissue. We tested the new indicator using in
vitro and in vivo experiments demonstrating the high sensitivity of CaRuby-Nano as well as its power
in dual color imaging experiments.
DOI: 10.7554/eLife.05808.001
Introduction
In recent years fluorescence imaging has been one of the fastest growing methods in physiology, cell
biology and neuroscience, constantly driving the need for improved fluorescent probes (Wilt et al.,
2009; Miyawaki, 2011; Looger and Griesbeck, 2012). The dominance of fluorescein and eGFP in
the design of such probes has resulted in an overcrowding of the green spectral band. This makes
simultaneous imaging of spatially overlapping signals problematic and emphasizes the need for
red-shifted probes (Oheim et al., 2014). Many of the very favorable photophysical properties of
fluorescein and eGFP are shared by the X-Rhodamine chromophore, which is finding increasing use in
the development of Ca2+-indicators (Eberhard and Erne, 1991; Egawa et al., 2011). A major problem
of red-shifted fluorophores is that they are significantly more lipophilic than fluorescein-like dyes.
This leads to more leakage through cell membranes as well as to intracellular compartmentalization.
These effects can be minimized by using the probes as conjugates of inert hydrophilic compounds
such as dextrans. This conjugation commonly uses one of the carboxylic groups of the BAPTA
moiety, affecting the calcium affinity of BAPTA-based indicators (Tsien, 1980). Consequently, these
indicator-dextran conjugates are strongly shifted to lower affinities making them all but useless for
sensitive and quantitative [Ca2+] measurements. Importantly, this lower affinity cannot be compensated
for by increasing the concentration of the probe. Such a strategy would lead to a disproportionally
large increase in the calcium buffering capacity of the indicator (Neher, 2005), resulting in
a stronger disruption of cellular signaling than for a low concentration of high affinity indicator
(Markram et al., 1998).
We recently introduced a family of red emitting calcium indicators based on X-Rhodamine:
Calcium Ruby (CaRuby) (Collot et al., 2012), which bears an azido side arm for click chemistry and
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the resulting potential for high-yield coupling reactions (Kolb et al., 2001). This side arm efficiently
allows conjugation reactions without significant perturbation of the calcium binding affinity
(Zamaleeva et al., 2014). The dissociation constants of CaRubies ranged from 3.4 to 21.6 μM—too
high for the reliable detection of small [Ca2+] transients in biological tissue (Yasuda et al., 2004) (see
Appendix 1 for details).
Results
To increase the affinity of CaRuby, we modified the structure of the probe (Figure 1A), focusing on
the Ca2+ chelating BAPTA moiety, as increasing the electron density of BAPTA lowers its KD for
calcium (Tsien, 1980). We introduced an oxygen atom on one of the aromatic rings of BAPTA by a
SNAr reaction. This oxygen also serves as a link for the azido side arm, which was repositioned in the
new CaRuby variant (Figure 1—figure supplement 1). Additionally, the fluorophore, which is com-
monly placed para to the nitrogen of the BAPTA, has an affinity-lowering effect due to its electron
withdrawing nature and was therefore placed at a meta position in order to reduce its effect on the
ligating nitrogen. These modifications resulted in a CaRuby variant with sub-micromolar affinity
(‘CaRuby-Nano’). In cuvette calibration experiments CaRuby-Nano was found to have a KD of 258 ± 8 nM,
with a 50-fold (±2) increase of fluorescence on binding [Ca2+] (Figure 1B–C) and a maximum quantum
yield of 0.45 (Figure 1—figure supplement 2,3). In addition to being suitable for single photon
excitation, CaRuby-Nano also exhibits effective two-photon excitation over a large wavelength band
(Figure 1—figure supplement 4).
For verification of the new probe in biological tissue we used conjugates with 1.5 kD and 6 kD
dextrans, which were obtained via click chemistry. As expected, this conjugation had only a small
eLife digest The movement of calcium ions within cells controls many vital biological processes,
ranging from cell growth to muscle contraction and brain activity. These calcium signals are triggered
by stimuli, such as nerve impulses, which drive calcium entry into cells or release calcium from internal
stores. These changes in calcium levels can span several orders of magnitude, and can be either
localized to very small parts of the cell or span the entire cell.
Scientists have developed numerous indicators or ‘probes’ that can detect even very low levels of
calcium. One common method uses proteins that fluoresce when viewed under a fluorescence
microscope each time the protein senses increases of calcium. Most of these probes fluoresce green,
and so to view a second signal that occurs in the cell at the same time it’s easier to use a probe that
fluoresces with a different color, such as red. However, the red-shifted probes that are currently
available either produce unreliable results because they tend to leak through cell membranes, or are
not very sensitive to calcium ions. New types of red-shifted probes are therefore urgently needed.
In 2012, researchers developed a family of red fluorescent probes known as Calcium Ruby
(CaRuby for short) that were more versatile than earlier red probes. Now, Collot, Wilms et al.—
including several of the researchers involved in the 2012 research—have enhanced the properties of
CaRuby by modifying the chemical structure of the probes. This increased the ability of CaRuby to
bind calcium ions, making it more sensitive to small calcium changes. Testing the usefulness of the
newly developed probes—called CaRuby Nano—in mouse nerve cells revealed the probes are highly
sensitive and can even detect the calcium signal resulting from a single nerve impulse.
Collot, Wilms et al. then went on to demonstrate that CaRuby-Nano can be used alongside
a green-fluorescing probe to record two signals at the same time. In one experiment, the release of
chemical messengers known as neurotransmitters was stimulated, which caused calcium ions to flow
into the observed nerve cells. The researchers succeeded in simultaneously detecting a green signal
indicating an increase in neurotransmitter levels and a red signal produced by the corresponding
release of calcium. Such dual-color imaging was not possible with previous probes. Finally, it was
shown that CaRuby-Nano can also be used to produce dual-color images of the brain activity of live
mice.
In summary, these results demonstrate that CaRuby-Nano is a highly sensitive and versatile
indicator and can be used together with other probes to observe two simultaneous events in cells.
DOI: 10.7554/eLife.05808.002
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effect on the affinity of the indicator, increasing the KD from 258 nM in the free salt to 295 nM in the
6 kD dextran conjugate (Figure 1—figure supplement 5).
We first tested if CaRuby-Nano performs comparably to commonly used green emitting [Ca2+]
probes. For this, Purkinje cells in acute cerebellar brain slices were filled with CaRuby-Nano (1.5
kD dextran) via a patch-clamp microelectrode (Figure 1D). Climbing fiber stimulation evoked
calcium signals were recorded from multiple spines (range: 4 to 14) at acquisition rates between
2.2 and 5.0 kHz (Figure 1E,F) using random access two-photon microscopy (Otsu et al., 2008).
The rising phase time course (0.55 ms ± 0.13 ms; sigmoidal fit; n = 59 spines from 7 cells) was
not significantly different from that found for Fluo-5F (0.40 ± 0.09 ms, n = 36 spines from 4 cells,
p = 0.37) under the same conditions, suggesting that CaRuby-Nano has binding kinetics
comparable to established small molecule Ca2+ indicators. These fast kinetics point to a high
Figure 1. Chemical and photophysical properties of CaRuby-Nano. (A) Structure of CaRuby-Nano. Note the oxygen
substituent and the positioning of the fluorophore-BAPTA bond. (B) [Ca2+]-dependent change in CaRuby-Nano
fluorescence ([Ca2+]free: 0 nM, 17 nM, 38 nM, 65 nM, 100 nM, 150 nM, 225 nM, 351 nM, 602 nM, 1.35 μM, 39 μM).
(C) The titration curve corresponding to the spectra in (B) using the same color code. (D–F): Climbing fiber evoked
dendritic calcium signals in Purkinje cells in vitro. (D) Purkinje cell filled with 300 μM CaRuby-Nano dextran, with
region of interest indicated by the white rectangle (scale bar = 20 μm). (E) Region of interest with points of interest
indicated. Note that many spines can be readily distinguished (white arrow). Points 1–3 and 4–6 are on different
spiny branchlets while points 7 and 8 are background (scale bar = 5 μm). (F) Ca2+ transients following climbing fiber
activation recorded at 2.8 kHz (traces averaged over 26 trials and then averaged over the indicated spine numbers).
DOI: 10.7554/eLife.05808.003
The following figure supplements are available for figure 1:
Figure supplement 1. Comparison of CaRuby structures.
DOI: 10.7554/eLife.05808.004
Figure supplement 2. Absorption and emission spectra of CaRu-Nano.
DOI: 10.7554/eLife.05808.005
Figure supplement 3. Determination of CaRuby-Nano fluorescence quantum yield.
DOI: 10.7554/eLife.05808.006
Figure supplement 4. Two-photon excitation of CaRuby-Nano.
DOI: 10.7554/eLife.05808.007
Figure supplement 5. Affinity of CaRuby-Nano and CaRuby-Nano 6 kD dextran.
DOI: 10.7554/eLife.05808.008
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sensitivity of CaRuby-Nano for small and fast changes in [Ca2+], such as neuronal action potentials
(Otsu et al., 2014).
Thus, we next tested the sensitivity of CaRuby-Nano using in vivo patch-clamp recordings from
neocortical layer 2/3 pyramidal neurons in anesthetized mice with simultaneous two-photon [Ca2+]
imaging (Svoboda et al., 1997) (Figure 2A). We found that using CaRuby-Nano (6 kD dextran) even
single spikes resulted in reliable, easily detected fluorescence transients (mean dR/R0 = 0.52 ± 0.19,
n = 6 cells; Figure 2B). For increasing spike numbers the dR/R0 vs spike number relation quickly turns
sublinear and saturates as expected for high affinity indicators (Figure 2C). Taken together these
experiments demonstrate that CaRuby-Nano is a calcium indicator with a signal quality comparable to
previously used high-affinity green emitting probes. Importantly, it is well suited for the detection of
small [Ca2+] transients, setting it apart from the previous CaRuby versions.
Having verified the suitability of CaRuby-Nano for single cell imaging experiments in vitro and in
vivo, we now set out to test CaRuby-Nano for imaging neuronal network activity when applying
sensory stimulation. In the past decade calcium population imaging has commonly been performed
using bulk loading (Stosiek et al., 2003; Ohki et al., 2005) of calcium indicators in the AM-ester form
(Tsien, 1981). We thus synthesized an AM-ester of CaRuby-Nano and used it to load cerebellar
neurons in vivo (Figure 3A). We performed a series of three experiments. In all cases we found labeling
identical to that commonly found in experiments using Oregon Green-488 BAPTA-1 AM (OGB-1 AM) to
load cerebellar tissue in vivo (Figure 3B) (Sullivan et al., 2005; Ozden et al., 2009; Schultz et al.,
2009). In all experiments fluorescence traces extracted from identified Purkinje cell dendrites
(Figure 3C) showed clear complex spike activity with a good signal-to-noise ratio (Figure 3D,F).
Both spontaneous activity and sensory evoked responses were again comparable to signals detected
in experiments using OGB-1 AM (Sullivan et al., 2005; Ozden et al., 2009; Schultz et al., 2009).
These results indicate that CaRuby-Nano AM is a powerful addition to the optophysiological toolbox.
To demonstrate the full power of CaRuby-Nano, we made use of the strong two-photon excitation
spectral overlap with eGFP to conduct a set of experiments which were not possible previously:
simultaneous imaging of glutamate release onto Purkinje cells using iGluSnFR (a single-wavelength
extracellular glutamate indicator constructed from the bacterial glutamate sensor Gltl and circularly
permutated GFP [Marvin et al., 2013]) and the resulting post-synaptic [Ca2+] increase (using CaRuby-
Nano). Visually identified Purkinje cells showing iGluSnFR expression (7–9 days after viral transfection)
were filled with CaRuby-Nano via patch-clamp recording (6 kD dextran; Figure 4A). Activation of the
glutamatergic climbing fiber input evoked clear fluorescence transients in both color channels
(Figure 4B). Glutamate signals were confined to distinct subsections of the dendritic tree (i.e., limited
Figure 2. Spike evoked transients in layer 2/3 pyramidal neurons in vivo. (A) Measurement configuration (left) and maximum intensity projection of
pyramidal neuron filled with 100 μMAlexa Fluor 488 and 200 μMCaRuby-Nano dextran (right, at rest the fluorescence is dominated by the green dye). The
red line indicates region imaged in line scan. Scale bar: 20 μm. (B) Single trial calcium signals evoked by increasing number of spikes. The corresponding
membrane voltage traces are shown below. Fluorescence traces are aligned to spike onset and color-coded to match the number of APs. (C) The peak
amplitudes (red) and the area under the curve (blue) of the fluorescence trace were plotted against the number of action potentials. While the area
increases linearly, the peak amplitude saturates. The shaded regions indicate the corresponding standard deviations.
DOI: 10.7554/eLife.05808.009
Collot et al. eLife 2015;4:e05808. DOI: 10.7554/eLife.05808 4 of 18
Tools and resources Cell biology | Neuroscience
to sites of synaptic glutamate release), whereas the resulting [Ca2+] transients were global, with similar
amplitudes throughout different regions of the dendritic tree (Figure 4C) (Lev-Ram et al., 1992).
The differential spatial distribution of the signals confirms that the two indicators can be spectrally
isolated.
To demonstrate that dual color imaging is also possible in vivo we used CaRuby-Nano (6 kD
dextran) to report presynaptic activity in anesthetized Kv3.1-eYFP adult mice (Metzger et al., 2002).
In the olfactory bulb of these mice, mitral and tufted cells, as well as a population of periglomerular
neurons, strongly express eYFP and their somata and processes clearly demarcate the external
glomerular boundaries (Figure 4D). Olfactory sensory neuron (OSN) terminals, labeled with CaRuby-
Nano, filled the inner glomerular boundaries (Figure 4E). In single glomeruli (n = 8 animals) we could
record presynaptic calcium responses with excellent signal to noise ratio. Figure 4F shows a typical
example in which presynaptic calcium responses were selectively evoked by odor presentation in a
Figure 3. Imaging cerebellar Purkinje cells in vivo using bulk loading of CaRuby-Nano AM. (A) Configuration of AM-ester injection and imaging.
(B) Resulting staining of tissue 60 min after injection of indicator. Purkinje cells can be seen as vertical stripes with occasional brighter spots (corresponding
to dendrites; scale bar = 20 μm). (C) Active Purkinje cell dendrites identified using a spatial PCA/ICA algorithm (Ozden et al., 2009). (D) Fluorescence
traces from the identified dendrites, using the same color code as in (C). The timing of the sensory stimulus (foot shock) is indicated by the underlying grey
bars. (E) Stimulus triggered averages of 20 stimulus presentations. Note that all cells except for the third (orange) show a stimulus-locked response.
DOI: 10.7554/eLife.05808.010
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subset of glomeruli. These responses adapted strongly at this high odorant concentration, as reported
previously (Lecoq et al., 2009). Taken together, these last two experiments demonstrate the potential
of two-channel functional imaging—both in vitro and in vivo—with the red emission and high sensitivity
Figure 4. Dual color functional imaging in vitro and in vivo. (A–C) Combined imaging of [glutamate] and [Ca2+] in
vitro (A) A Purkinje cell expressing iGluSnFR was filled with 200 μM CaRuby-Nano dextran. The image shows the
basal fluorescence of CaRuby-Nano (scale bar = 5 μm). (B) Double pulse stimulation of the climbing fiber
triggers spatially distinct patterns of glutamate release and Ca2+ influx (maximum dF/F0 images; the inset at the
top shows the two evoked complex spikes). Note the breaks between regions showing iGluSnFR activation
(indicated by white arrows) (C) Fluorescence traces for CaRuby-Nano (red) and iGluSnFR (green) following single
pulse climbing fiber stimulation (top inset). Traces were extracted from the corresponding regions outlined in
white in (B). Note the absence of a fluorescent transient for iGluSnFR in the ‘Ca2+ only’ region. (D–F) Odor-
evoked calcium responses in olfactory bulb glomeruli in vivo. (D) Juxtaglomerular neurons and mitral cell
dendritic tufts expressing YFP demarcate glomeruli in a Kv3.1-eYFP mouse (Metzger et al, 2002). (E) Olfactory
sensory neuron glutamatergic terminals, labeled with CaRuby-Nano dextran, clearly filled the inner boundaries
of most glomeruli. (F) A 3 s application of 30% isoamyl acetate reliably triggered presynaptic calcium responses
in several glomeruli.
DOI: 10.7554/eLife.05808.011
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of CaRuby-Nano being an ideal match for numerous other indicators emitting in the green-yellow
spectral band.
Discussion
We have developed a high-affinity red-emitting calcium indicator. This novel indicator, CaRuby-Nano,
has a KD of 295 nM (for the dextran conjugate). This makes CaRuby-Nano only slightly higher affinity
than the commonly used green emitting indicator Fluo-4 (335 nM). On calcium binding CaRuby-Nano
shows a 50-fold fluorescence increase (vs. 14-fold and 100-fold for OGB-1 and Fluo-4, respectively).
The quantum efficiency of calcium bound CaRuby-Nano (0.45) is lower than that of OGB-1 (∼0.7) but
significantly higher than that of Fluo-4 (∼0.14). These values classify CaRuby-Nano as an ideal indicator
for the quantification of small intracellular [Ca2+] transients (see Appendix 1). Using a range of different
experiments we have demonstrated that CaRuby-Nano is well suited for both in vitro and in vivo imaging
experiments requiring high sensitivity to [Ca2+] changes. Finally, we show that CaRuby-Nano can be
combined with activity indicators emitting in the green-yellow spectral band, to allow multiplexed
imaging. The versatility of the probe is further increased by the azido function, which can easily be
reduced to an amine group, thus opening the field to functionalization with numerous molecular tools
such as antibodies, benzylguanine (SNAP tag) or peptides to facilitate specific sub-cellular targeting.
CaRuby-Nano’s sensitivity and potential for spectral multiplexing allows sophisticated experiments
such as simultaneously measuring pre- and postsynaptic activity or imaging of different signaling
modalities in the same cell, allowing previously elusive questions to be directly addressed.
Materials and methods
General chemical methods
All the solvents were of analytical grade. Chemicals were purchased from commercial sources. 1H-NMR
and 13C-NMR were measured on a Bruker Avance III-300 MHz spectrometer (Bruker Biospin, The
Woodlands, TX, USA) with chemical shifts reported in ppm (TMS as internal standard). Mass spectra
were measured on a Focus GC/DSQ II spectrometer (ThermoScientific, Waltham, MA, USA) for IC and
an API 3000 spectrometer (Applied Biosystems, PE Sciex) for ES. All pH measurements were made with
a Mettler Toledo pH meter. Fluorescence spectra were recorded on a JASCO FP-8300 spectrofluo-
rometer (JASCO, Easton, MD, USA). Absorption spectra were determined on a VARIAN CARY 300 Bio
UV-Visible spectrophotometer. All measurements were done at a temperature of 25˚C. The purity of the
dyes were checked by RP-HPLC C-18, elutant: ACN 0.1% TFA/Water 0.1% TFA, method: 20/80 to 100/
0 within 20 min then 100/0 for 10 min detection at λAbs = 254 nm. The apparent dissociation constant for
calcium (KD Ca
2+) was measured with a calcium calibration buffer kit from Invitrogen (Lifetechnologies,
USA). All mass spectra, NMR spectra and chromatograms are included as supplemental data.
Design of CaRuby-Nano from the first generation CaRubies
In order to develop a high affinity CaRuby, three modifications were carried out based on the first
generation CaRubies. First, an oxygen atom was introduced on one of the BAPTA’s cycles in order to
electronically enrich the latter. Then, this oxygen atom served as an anchor to a spacer terminated by an
azide function for further functionalizations either by click chemistry or by reducing it into an amine for
coupling with for example, a carboxylic acid. Finally, the fluorophore moiety, an extended rhodamine
which is positively charged and therefore has an electron withdrawing effect, was moved from the para
position of the aniline to the meta position. As expected, these modifications lead to a significant
increase of affinity towards calcium, yielding a CaRuby with a dissociation constant of 258 ± 8 nM.
Synthesis of CaRuby-Nano
The synthesis pathway is displayed in Figure 5 along with the compound numbering. The NMR and mass
spectra for both intermediate compounds and final products are contained in Supplementary file 1.
To a solution of de 5-fluoro-2-nitrophenol (14.90 g, 94.84 mmol) in DMF (75 ml) were added
dibromoethane (40.90 ml, 472.2 mmol, 5 eq) and K2CO3 (26.30 g, 189.7 mmol, 2 eq), the mixture was
allowed to stir at 70˚C for 2 hr. The solvents were evaporated and the product was extracted with
EtOAc washed with water (three times) and brine (two times). The organic phase was dried over
MgSO4, filtered and evaporated to reach a volume of 200 ml. The symmetric dinitro compound
Collot et al. eLife 2015;4:e05808. DOI: 10.7554/eLife.05808 7 of 18
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crystallizes first and was filtered off. The filtrate was then allowed to crystallize to obtain 20.12 g of
1 (80%) as a yellow powder. 1H-NMR (300 MHz, DMSO-d6): δ 8.04 (dd, Ja-b = 9.1 Hz, Ja-F = 6.1 Hz, 1H,
Ha), 7.37 (dd, Jc-F = 11.0 Hz, Jc-b = 2.6 Hz, 1H, Hc), 7.02 (ddd, Jb-a = 9.1, Jb-F = 7.8 Hz, Jb-c = 2.6 Hz, 1H,
Hb), 4.56–4.53 (m, 2H, CH2O), 3.84−3.81 (m, 2H, CH2Br). 13C-NMR (75 MHz, DMSO-d6): δ 164.82
Figure 5. Synthesis of CaRuby-Nano and CaRuby-Nano AM ester.
DOI: 10.7554/eLife.05808.012
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(d, 1JF-C = 251 Hz, CF), 152.81(d, 3JC-F = 12 Hz, CO), 136.17 (d, 4JF-C = 3 Hz, CNO2), 127.62
(d, 3JF-C = 11 Hz, Ca), 108.01 (d, 2JF-C = 23 Hz, Cb), 103.45 (d, 2JF-C = 27 Hz, Cc), 69.78 (CH2O),
30.39 (CH2Br). MS (CI), calculated for C8H11BrFN2O3 [M + NH4]+ 280.9, found 281.0.
To a solution of 1 (19.79 g, 74.96 mmol) in DMF (75 ml) were added 2-nitrophenol (11.46 g,
82.45 mmol, 1.1 eq) and K2CO3 (15.63 g, 112.4 mmol, 1.5 eq), the mixture was allowed to stir
overnight at 70˚C. The solvent was evaporated and the product was extracted with DCM,
washed with HCl (1 M) and brine (2 times). The organic phase was dried over MgSO4, filtered and
evaporated to reach a volume of 200 ml. The product crystallized and was filtered to obtain
12.00 g of 2 (50%) as a yellow powder. 1H-NMR (300 MHz, DMSO-d6): δ 8.01 (dd, Ja-b = 9.1 Hz,
Ja-F = 6.1 Hz, 1H, Ha), 7.86 (dd, Jg-f = 8.1 Hz, Jg-e = 1.6 Hz, 1H, Hg), 7.67 (ddd, 3J = 8.5, 7.4, 4Je-g = 1.7 Hz,
1H, He), 7.45-7.39 (m, 2H, Hc, Hd), 7.15 (ddd,
3J = 8.1 Hz, 7.4 Hz, 4J = 1.1 Hz, 1H, Hf), 7.01 (ddd Jb-a = 9.1,
Jb-F = 7.8 Hz, Jb-c = 2.6 Hz, 1H, Hb), 4.59-4.54 (m, 4H, 2CH2O). 13C-NMR (75 MHz, DMSO-d6): δ 164.86
(d, 1JF-C = 251 Hz, CF), 153.34 (d, 3JC-F = 11.9 Hz, CO), 150.82 (Cq Ar), 139.74 (Cq Ar), 136.15
(d, 4JF-C = 3.7 Hz, CNO2), 134.33 (Ce), 127.58 (d, 3JF-C = 11 Hz, Ca), 124.85 (Cg), 121.05 (Cf),
115.55 (Cd), 107.90 (d,
2JF-C = 24 Hz, Cb), 103.57 (d, 2JF-C = 27.7 Hz, Cc), 68.57 (CH2O), 67.93
(CH2O). MS (ES+), calcd for C14H11FN2O6Na [M + Na]+ 345.0, found 345.3. HRMS (ES+), calcd
for C14H11FN2O6Na [M + Na]+ 345.0493, found 345.0501.
To a stirred solution of 2 (5.91 g, 18.34 mmol) in DMSO (53 ml) was added NaOH 20% (11.5 ml) the
solution turned yellow and was allowed to stir at room temperature overnight. 50 ml of water and 10
ml HCl (1 M) were then added and the product was extracted three times with EtOAc. The organic
phase was washed three times with water before being dried over MgSO4, the solution was filtered
and evaporated and crystallized in EtOAc to obtain 4.46 g of 3 (76%) as a yellow powder. 1H-NMR
(300 MHz, DMSO-d6): δ 7.90–7.85 (m, 2H, Ha, Hg), 7.67–7.64 (dd, 3J = 8.7 Hz, 4J = 1.5 Hz, 1H, He),
7.48 (d, 3J = 8.4 Hz, 1H, Hd), 7.16 (t, 3J = 7.7 Hz, 1H, Hf), 6.66 (d, 4J = 2.2 Hz, 1H, Hc), 6.51 (dd, 3J = 9.0,
4J = 2.2 Hz, 1H, Hb), 4.55–4.54 (m, 2H, CH2O), 4.45 (t, J = 3.8 Hz, 2H, CH2O). 13C-NMR (75 MHz,
DMSO-d6): δ 163.87 (Cq Ar), 154.51 (Cq Ar), 150.98 (Cq Ar), 139.79 (Cq Ar), 134.36 (Ce), 131.12
(Cq Ar), 128.18 (Ca or Cg), 124.86 (Ca or Cg), 121.03 (Cf), 115.75 (Cd), 108.01 (Cb), 101.56 (Cc), 68.06
(CH2O), 67.87 (CH2O). MS (CI), calcd for C14H16N3O7 [M + NH4]+ 338.0, found 337.7. HRMS (ES+),
calcd for C14H13N2O7 [M + H]+ 321.0717, found 321.0722.
To a solution of 3 (4.86 g, 15.19 mmol) in DMF (50 ml) were added dibromohexane (11.12 ml, 45.56
mmol, 3 eq) and K2CO3 (3.16 g, 22.78 mmol, 1.5 eq). The mixture was allowed to stir at 70˚C for 12 hr.
The solvents were evaporated and the product was extracted with EtOAc washed with water (three times)
and brine (two times). The organic phase was dried over MgSO4, filtered and evaporated. The crude was
purified by column chromatography on silica gel (Cyclohexane/EtOAc: 7/3) to obtain the crude 4 which
was crystallized in a mixture of EtOAc and cyclohexane (3/7) to obtain 2.97 g of pure 4 (40%) as a off
white powder. Rf = 0.22 (Cyclohexane/EtOAc, 7/3). 1H-NMR (300 MHz, CDCl3): δ 8.00 (d, J = 9.1 Hz,
1H, Ha), 7.86 (dd, J = 8.1, 1.6 Hz, 1H, Hg), 7.64–7.58 (m, 1H, He), 7.33 (dd (in solvent pick), 1H, Hd),
7.14–7.09 (m, 1H, Hf), 6.66 (d, J = 2.4 Hz, 1H, Hc), 6.57 (dd, J = 9.1, 2.4 Hz, 1H, Hb), 4.60–4.51
(m, 4H, 2CH2O), 4.08 (t, J = 6.4 Hz, 2H, CH2O), 3.47 (t, J = 6.7 Hz, 2H, CH2Br), 1.96–1.85 (m, 4H,
2CH2), 1.56 (dt, J = 7.1, 3.5 Hz, 4H, 2CH2). 13C-NMR (75 MHz, CDCl3): δ 164.35 (Cq), 154.63 (Cq),
151.96 (Cq), 140.43 (Cq), 134.37 (Ce), 133.34 (Cq), 128.32 (Ca), 125.56 (Cg), 121.43 (Cf), 116.14 (Cd),
106.89(Cb), 102.02 (Cc), 68.83 (CH2O), 68.70 (CH2O), 68.65 (CH2O), 33.81 (CH2Br), 32.63 (CH2),
28.85 (CH2), 27.86 (CH2), 25.19 (CH2). MS (ES+), calcd for C20H23BrN2O7Na [M + Na]+ 505.0, found
505.5. HRMS (ES+), calcd for C20H24BrN2O7 [M + H]+ 483.0767, found 483.0772.
To a solution of 4 (5.00 g, 10.35 mmol) in EtOAc (100 ml) and methanol (30 ml) was added Pd/C
(1.10 g). The solution was stirred and degassed before H2 was allowed to bubble in the solution for
5 hr. The solution was then filtered off celite and rinsed with EtOAc under an atmosphere of argon.
The solvents were evaporated and the crude was dissolved in acetonitrile (50 ml), to this solution were
added, methyl bromoacetate (12.0 ml, 124.2 mmol, 12 eq) and DIEA (23.0 ml, 124.2 mmol, 12 eq)
before being warmed up to 80˚C. The solution was allowed to stir overnight at 80˚C. The solvents were
evaporated, the product was extracted with DCM and washed with water. The organic phase was dried
over MgSO4, filtered and evaporated. The crude was purified by column chromatography on silica gel
(Cyclohexane/EtOAc: 7/3) to obtain 3.71 g of 5 (50%) as a yellowish syrup containing impurities
(between 2 and 3 ppm in 1H NMR) that could not be removed. Rf = 0.51 (Cyclohexane/EtOAc, 6/4).
1H-NMR (300 MHz, CDCl3): δ 6.85–6.74 (m, 5H), 6.39 (d, J = 2.7 Hz, 1H), 6.31 (dd, J = 8.7, 2.7 Hz, 1H),
4.20 (m, 4H, CH2O), 4.08 (s, 4H, 2CH2N), 4.02 (s, 4H, 2CH2N), 3.81 (t, J = 6.4 Hz, 2H, CH2O), 3.50
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(d, J = 7.4 Hz, 12H, 4 OMe), 3.36 (t, J = 6.8 Hz, 2H, CH2Br), 1.85–1.80 (m, 2H, CH2), 1.71-1.67 (m, 2H, CH2),
1.42 (t, J = 3.6 Hz, 4H, 2 CH2). MS (ES+), calcd for C32H43BrN2O11Na [M + Na]+ 735.2, found 735.8.
To a solution of 5 (3.71 g, 5.218 mmol) in DMF (10 ml) was added NaN3 (1.02 g, 15.65 mmol, 3 eq).
The solution was stirred at 80˚C overnight. The product was extracted with EtOAc and washed with
water (three times) and brine (two times), the organic phase was dried over MgSO4, filtered and
evaporated to give 3.52 g of 6 (quant) as a yellowish syrup. 1H-NMR (300 MHz, CDCl3): δ 6.84–6.73
(m, 5H), 6.39 (d, J = 2.5 Hz, 1H), 6.31 (dd, J = 8.7, 2.5 Hz, 1H), 4.19 (d, 4H, CH2O), 4.08 (s, 4H, 2CH2N),
4.01 (s, 4H, 2CH2N), 3.81 (t, J = 6.4 Hz, 2H, CH2O), 3.48 (d, J = 7.3 Hz, 12H, 4 OMe), 3.20 (t, J = 6.8 Hz,
2H, CH2N3), 1.70–1.64 (m, 2H, CH2), 1.60–1.51 (m, 2H, CH2), 1.38 (m, 4H, 2 CH2). Impurities between
2 and 3 ppm could not be removed. MS (ES+), calcd for C32H44N5O11 [M + H]+ 674.3, found 674.3. HRMS
(ES+), calcd for C32H44N5O11 [M + H]+ 674.3032, found 674.3054.
To a solution of 6 (1.22 g, 1.81 mmol) in DMF (5 ml) was added POCl3 (1.35 ml, 14.48 mmol, 8 eq)
dropwise without cooling. After addition the solution was allowed to stir for 40 min and then water
(50 ml) was added followed by slow addition of a saturated solution of NaHCO3 to reach a pH of 8.
The product was extracted with DCM and washed twice with brine before being dried over MgSO4
filtrated and evaporated. The crude was purified by column chromatography on silica gel (Cyclohexane/
EtOAc: 6/4) to obtain 505 mg of 7 (40%) as a yellow syrup. Rf = 0.25 (Cyclohexane/EtOAc, 5/5). 1H-NMR
(300 MHz, CDCl3): δ 10.23 (s, 1H, CHO), 7.27 (s, 1H, Ha), 6.86–6.75 (m, 4H, Hd, He, Hf, Hg), 6.39 (s, 1H,
Hc), 4.26 (d, J = 2.4 Hz, 4H, 2CH2O), 4.06 (d, J = 3.3 Hz, 4H, 2CH2N), 4.02 (d, J = 5.8 Hz, 4H, 2CH2N),
3.96 (t, J = 6.3 Hz, 2H, CH2O), 3.49 (2 s, 12H, 2 OMe), 3.22 (t, J = 6.8 Hz, 2H, CH2N3), 1.77 (t, J = 7.1 Hz,
2H, CH2), 1.57 (t, J = 7.0 Hz, 2H, CH2), 1.45–1.35 (m, 4H, CH2). 13C-NMR (75 MHz, CDCl3): δ 187.99
(CHO), 171.94 (COOMe), 171.64 (COOMe), 158.88 (Cq Ar), 157.35 (Cq Ar), 150.21 (Cq Ar), 139.40 (Cq
Ar), 133.40 (Cq Ar), 122.44 (CH Ar), 121.86 (CH Ar), 119.19 (CH Ar), 118.28 (Cq Ar), 118.07 (Ca), 113.45
(CH Ar), 97.79 (Cc), 68.93 (CH2O), 67.53 (CH2O), 66.81 (CH2O), 53.36 (2CH2N), 53.32 (2CH2N), 51.69
(OMe), 51.65 (OMe), 51.35 (CH2N3), 30.19 (CH2), 29.07 (CH2), 28.82 (CH2), 26.92 (CH2), 26.50 (CH2),
25.70 (CH2). MS (ES+), calcd for C33H44N5O12 [M + H]+ 702.3, found 702.2. HRMS (ES+), calcd for
C33H44N5O12 [M + H]+ 702.2981, found 702.3008.
The position of the carbonyl was confirmed by further NMR investigations using a Heteronuclear
Multiple Bond Correlation (Supplementary file 2).
To a solution of aldehyde 7 (300 mg, 0.428 mmol) in propionic acid (5 ml) was added
8-hydroxyjulolidine (161 mg, 0.856 mmol, 2 eq) and PTSA (8 mg, 0.042 mmol, 0.1 eq). The solution was
protected from light and stirred at room temperature overnight. To the brown mixture was added a
solution of chloranil (103 mg, 0.428 mmol, 1 eq) in DCM (10 ml), the reaction turned dark and was
allowed to stir overnight at room temperature. The dark purple solution was evaporated to dryness.
The crude was purified by column chromatography on silica gel (gradient of 100% DCM to 9/1 DCM/
Methanol) to obtain 130 mg of 8 (30%) as a purple solid after lyophilisation (dioxane/water: 1/1).
Rf = 0.32 (DCM/MeOH, 9/1). 1H-NMR (300 MHz, CDCl3): δ 7.84 (d, J = 8.1 Hz, 1H, H Ar), 7.06 (d, J = 7.9,
1H, H Ar), 6.97–6.86 (m, 5H, H Ar, H7), 6.71 (d, J = 2.9 Hz, 1H, H Ar), 4.47–4.40 (m, 4H, CH2O), 4.21 (s,
4H, NCH2COOMe), 4.11 (s, 4H, NCH2COOMe), 3.87 (t, J = 6.1 Hz, 2H, CH2O), 3.67 (s, 6H, 2 OMe), 3.56
(m, 14H, 2 OMe, H1, H4), 3.11 (d, J = 7.0 Hz, 2H, CH2N3), 3.04 (t, J = 6.3 Hz, 4H, H6), 2.75 (q, J = 6.2 Hz,
4H, H3), 2.13–2.10 (m, 4H, H5), 2.00 (t, J = 5.5 Hz, 4H, H2), 1.49–1.34 (m, 4H, CH2), 1.19–1.03 (m, 4H,
CH2).
13C-NMR (75 MHz, CDCl3): δ 171.97 (CO ester), 171.56 (CO ester), 153.04 (C Ar), 152.74 (C Ar),
152.31 (C Ar), 152.09 (C Ar), 151.02 (C Ar), 150.43 (C Ar), 144.79 (C Ar), 139.41 (C Ar), 138.16 (C Ar),
132.61 (C Ar), 128.20 (CH Ar), 127.15 (CH Ar), 126.33 (CH Ar), 123.34 (C Ar), 122.64 (CH Ar), 122.61 (CH
Ar), 121.91 (CH Ar), 119.54 (CH Ar), 113.89 (C Ar) (CH Ar), 113.43 (C Ar), 113.35 (C Ar), 105.16 (C Ar),
69.10 (CH2O), 67.70 (CH2O), 67.19 (CH2O), 53.66 (NCH2COOMe), 53.52 (NCH2COOMe), 51.73 (4
OMe), 51.16 (CH2N3), 50.97 (C1 or C4), 50.52 (C1 or C4), 28.82 (CH2), 28.73 (CH2), 27.72 (C3), 26.26
(CH2), 25.52 (CH2), 20.83 (C2), 20.00 (C6), 19.85 (C5). MS (ES+), calcd for C57H68N7O12 [M]+ 1042.5,
found 1042.9. HRMS (ES+), calcd for C57H68N7O12 [M]+ 1042.4920, found 1042.4949.
To a solution of 8 (100 mg, 0.090 mmol) in methanol (6 ml) were added, KOH (504 mg, 9.00 mmol,
100 eq) followed by 2 ml of water, the mixture was stirred overnight. The product was washed with
HCl (1 M) and extracted with CHCl3 until the aqueous phase become slightly pink. The organic phase
was then dried over MgSO4, filtered and evaporated. The crude was purified on a reverse phase column
C-18 using acetonitrile (0.1% TFA) and water (0.1% TFA) as eluant (20% ACN to 60%). The solvents were
evaporated and 80 mg of CaRuby-Nano (∼90%) were obtained as a purple solid after lyophilisation
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(dioxane/water, 1/1). MS (ES+), calcd for C53H60N7O12 [M]+ 986.4, found 986.4. HRMS (ES+), calcd for
C53H60N7O12 [M]
+ 986.4294, found 1042.4329.
To a solution of CaRuby-Nano (50 mg, ∼50 μmol) in chloroform were added bromomethyl acetate
(80 μl, 500 μmol, 1 eq) and NEt3 (60 μl, 400 μmol, 8 eq). The solution was protected from light and
allowed to stir at room temperature overnight. The reaction was monitored by TLC (DCM/MeOH,
9/1). The solvents were evaporated and the crude was purified by column chromatography on silica
gel (gradient of 100% DCM to 9/1 DCM/Methanol) to obtain 30 mg of CaRuby-Nano AM esters
(∼45%) as a purple solid after lyophilisation (dioxane/water, 1/1). Rf = 0.45 (DCM/MeOH, 9/1). MS (ES+),
calcd for C65H76N7O20 [M]
+ 1274.5, found 1274.5. HRMS (ES+), calcd for C65H76N7O20 [M]+ 1274.5140,
found 1274.5128.
Synthesis of dextran conjugates
Dextran 6000 MW (Sigma–Aldrich, ref: 31388) and dextran 1500 MW (Sigma–Aldrich, ref: 31394) were
propargylated as described by Nielsen et al. (2010). The 1H-NMR showed that the functionalized
dextrans were propargylated once by unit.
Final MW Dextran 6000: ∼9800 g.mol−1.
Final MW Dextran 1500 : ∼2400 g.mol−1.
Conjugation of dextran 6000
To a solution of propargylated dextran 6000 (30 mg, ∼3 μmol) in water (3 ml) was added 9 (8 mg, 8 μmol,
2.6 eq) in methanol (1 ml) and an heterogeneous solution of CuSO4·5H2O (4 mg, 16 μmol, 5.3 eq) and
sodium ascorbate (4 mg, 20 μmol, 6.6 eq) in water (500 μl). The solution was allowed to stir in the dark at
room temperature overnight. The solvents were evaporated and the crude was dissolved in 1 ml of EDTA
solution (0.1 M) and passed through a G-25 column to give 24 mg of CaRu-Dextran 6000 conjugate
(∼60% yield).
Conjugation of dextran 1500
To a solution of propargylated dextran 1500 (30 mg, ∼12.5 μmol) in DMF (1 ml) was added 9 (4.5 mg,
4.5 μmol, 0.3 eq) in DMF (200 μl) and a heterogeneous solution of CuSO4·5H2O (4 mg, 16 μmol, 1.3 eq)
and sodium ascorbate (4 mg, 20 μmol, 1.6 eq) in water (100 μl). The solution was allowed to stir in the
dark at 50˚C overnight. The solvents were evaporated and the crude was dissolved in 1 ml of EDTA
solution (0.1 M) and passed through a G-25 column to give 20 mg of CaRu-Dextran 1500 conjugate
(∼58% yield).
Animals
All procedures were approved by the local ethical review committee and performed under license
from the UK Home Office in accordance with the Animals (Scientific Procedures) Act 1986, and in
accordance with the Institut National de la Sante´ et de la Recherche Me´dicale (INSERM) Animal Care
and Use Committee Guidelines and with Centre National de la Recherche Scientifique (CNRS) animal
experimentation guidelines and European laws and policies, as applicable.
Slicing
Parasagittal cerebellar slices (200 μm) were made using standard techniques (Davie et al., 2006) from
C57BL6/J mice (Harlan, UK) at postnatal days 25–29. Artificial CSF (ACSF) for both slicing and recording
contained the following (in mM): 125 NaCl, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 25 glucose, 1 MgCl2,
and 2 CaCl2, and was bubbled with 5% carbon dioxide, 95% oxygen. Slices were continuously
superfused with ACSF during the experiment.
For high speed imaging experiments, acute 260 μm thick slices were obtained from the cerebellar
vermis of P60 CD1 mice and superfused with ACSF, as previously described (Dugue et al., 2009).
Electrophysiology and imaging in cerebellum and neocortex
Full frame and linescan two-photon imaging was performed using microscopes optimized for in vitro
(Prairie Technologies, now Bruker Nano Surfaces, USA) or in vivo (MOM, Sutter, Novato, CA, USA)
experiments. Two photon excitation was provided by a pulsed Ti:Sa laser (MaiTai HP, Spectra-Physics,
Santa Clara, CA, USA), tuned to a central wavelength of 890–920 nm. The microscopes were controlled
by ScanImage 3.5 and 3.7.1 (Pologruto et al., 2003) (now Vidrio Technologies, Arlington, VA, USA).
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For two-color imaging of iGluSnFR and CaRuby-Nano the Ti:Sa was tuned to 900 nm. Fluorescence
light was split into red and green channels using dichroic mirrors (575/DCXR, Chroma, Bellows Falls,
VT, USA) and bandpass filtered (green: 525/50; red: 607/45; both: Semrock, Lake Forest, IL, USA).
Patch-clamp pipettes were filled with an internal solution containing (in mM): K-methanesulfonate
133, KCl 7, HEPES 10, Mg-ATP 2, Na2ATP 2, Na2GTP 0.5, EGTA 0.05, 0.1 Alexa Fluor 488 and
CaRuby-Nano dextran as indicated; pH 7.2. Recordings from visually identified Purkinje cells were
made using a Multiclamp 700B amplifier (Molecular Devices, Sunny Vale, CA, USA). Data were
lowpass filtered at 4 kHz and acquired at 20 kHz using an ITC-18 digitizer (HEKA Intruments, Bellmore,
NY, USA) controlled by AxoGraph X (AxoGraph Scientific, Sydney, Australia). Electrical stimuli were
delivered via a theta-glass bipolar electrode filled with ACSF using a constant current stimulus isolator
(DS-3, Digitimer, Letchworth Garden City, UK). When using electrical stimulation, 10 μM SR-95531
(Sigma or Tocris) was added to the perfusion medium.
Climbing fiber stimulation-evoked transient [Ca2+] changes in Purkinje cell spines were recorded at
high acquisition rate (>2 kHz) by two-photon random-access microscopy, a technique based on the
use of acousto-optic deflectors (AODs), which enable selective scanning of defined points (Otsu et al.,
2008). Purkinje cells were recorded in current-clamp mode, using 2–3 MΩ patch pipettes containing
300 μM CaRuby-Nano dextran. Recordings were obtained by use of a Multiclamp 700B (Molecular
Devices). Following the dialysis of CaRuby-Nano, Purkinje cells in slices were imaged under a 25×
Leica water immersion objective (HCX IRAPO L 25×/0.95, Leica Microsystems, Wetzlar, Germany).
Two-photon excitation was produced by a pulsed Ti:Sa laser (Chameleon Vision Plus, Coherent, Santa
Clara, CA, USA) coupled into the transmitted light pathway of the microscope by a dichroic filter
(740dcsx, Chroma) and tuned to a central wavelength of 890 nm. A custom-made user interface based
on National Instrument cards programmed under Labview (both National Instruments, Austin, TX,
USA) was used to operate the AODs and coordinate the scanning protocols and signal acquisition.
A multifunction card (NI-PCI-MIO 16 E-4) was used to pass all the triggers necessary to synchronize the
imaging and the electrophysiology and to control the piezo-electric device that moves the objective in
Z. Fluorescence photons were detected by cooled AsGaP photomultipliers (H7421-40, Hamamatsu,
Hamamatsu, Japan) discriminated and counted on a fast digital card.
Virus injection
Young (P19) C57BL6/J mice were anesthetized using isoflurane, an incision was made into the scalp
and a small (∼0.5 mm) craniotomy was performed over lobule V of the cerebellar vermis. A wide bore
(∼50 μm) micropipette containing viral suspension (AAV1.hSyn.iGluSnFr.WPRE.SV40, University of
Pennsylvania Vector Core) was inserted through the craniotomy and carefully lowered 1.0 mm into the
brain. Using application of low pressure 400–800 nl viral suspension were slowly injected (10–20 min).
After the injection further 5–10 min were waited before retraction of the injection pipette. The scalp
was glued and sutured and the mouse left to recover. At least 7 days incubation time were allowed
prior to further experiments.
In vivo imaging of olfactory sensory neuron terminals
Kv3.1-eYFP mice (Metzger et al., 2002) (8–10 week-old) were anesthetized with an intraperitoneal
injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). CaRuby-Nano dextran (6 kDa) was dissolved
2.5% wt/vol in a solution of aCSF (in mM: 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 1 MgCl2,
2 CaCl2 and 25 glucose) with 0.2% Triton X-100 (Sigma–Aldrich). 8 μl of this solution was injected in the
mouse naris, and mice were left on their backs to recover from anesthesia (protocol adapted from
[Wachowiak and Cohen, 2001; Lecoq et al., 2009]). 7 days later, an acute craniotomy was performed
over the dorsal olfactory bulb and the brain stabilized with 3.5% agar for imaging. To activate olfactory
sensory neurons (OSNs), odors were applied in a 1 ml/min flux of filtered, humidified air supplemented
with 30% oxygen. eYFP and CaRuby-Nano fluorescence was collected in two separate channels (‘green’
and ‘red’, respectively) of a custom-built two-photon laser scanning microscope, with the femtosecond
pulsed excitation beam set to 910 nm.
In vivo bulk loading and imaging
Adult C57BL6 mice (6–9 weeks) were anesthetized with isoflurane, supplemented with 1 mg/kg
chlorprothixene. A 1.5–2 mm craniotomy was performed over cerebellar lobule V. Care was taken to
leave the dura mater intact. CaRuby-Nano-AM was prepared and injected using standard methods
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(Stosiek et al., 2003; Sullivan et al., 2005). A 50 μg aliquot was dissolved in 20% Pluronic-127 in
DMSO (Invitrogen) and then diluted 1:10 in saline (150 mM NaCl, 2.5 mM KCl, 10 mM HEPES, pH 7.4).
This solution was filtered and injected into the cerebellum under visual guidance using a patch-pipette
and 500–750 mbar pressure for 1–3 min. After injection the preparation was left to incubate for up to
1.5 hr prior to imaging. This helped improve labeling and lower unspecific fluorescence.
Data analysis and statistics
Imaging data were analyzed using ImageJ (http://rsbweb.nih.gov/ij/). Extracted fluorescence traces,
linescans and electrophysiological data were analyzed using in house routines programmed in Igor
Pro versions 5 or 6.2 (Wavemetrics) and in pClamp 10 (Molecular Devices). Statistical analysis was
performed in Matlab (MathWorks, Natick, MA, USA) or Igor Pro (Wavemetrics, Portland, OR, USA).
Experimental groups were compared using a t-test and were assumed to be significantly different if
the found p-values were <0.05.
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Appendix 1
Technical Background: signal amplitude and SNR depend
on KD
The expected dF/F0 signal amplitude and signal-to-noise ratio (SNR) of a transient analyte-
dependent fluorescence increase is a major factor in determining the suitability of an indicator dye
for a given measurement. In Ca2+ imaging, the interplay between fluorescence gain (Fmax = Fpeak/
Fresting), indicator brightness, and indicator KD will determine the signal amplitude and SNR for
a given [Ca2+] transient amplitude. Assuming that dyes based on the same fluorophore have similar
brightness, the KD and the fluorescence gain will determine the suitability of indicators for
detecting [Ca2+] transients of a given size. Other factors, such as the need to remain in a linear
regime of the [Ca2+]-to-fluorescence relation or the need to avoid excessive Ca2+ buffering, will also
play a role in choosing the best suited indicator. As these factors have been discussed in detail
previously (Yasuda et al., 2004; Higley and Sabatini, 2008), we here focus only on signal
amplitude and SNR.
Depending on the size of a [Ca2+] transient, different affinity indicators will give the best
possible signal and SNR. Here we compare the recently published CaRuby-Me (KD = 3.4 μM;
gain = 62.5) and the novel indicator described in this publication, CaRuby-Nano, (KD = 258 nM;
gain = 50; see main text for details).
The basis for our calculations is following equation describing the relationship between [Ca2+]
and fluorescence intensity:
Fð½Ca2+ Þ =

Ca2+

KD
pFmax +

Fmax
dF

The resulting fluorescence vs [Ca2+] curves for both CaRuby-Me and CaRuby-Nano are shown in
Appendix figure 1A.
The signal size resulting from a given [Ca2+] transient is commonly reported as the dF/F0
amplitude (Yasuda et al., 2004). Assuming a resting [Ca2+] of 50 nM, the [Ca2+]peak
dependence of dF/F0 for CaRuby-Me and CaRuby-Nano is shown in Appendix figure 1B. This
analysis suggests that CaRuby-Nano would have a small advantage in signal size over CaRuby-
Me for [Ca2+] transients not exceeding 269 nM.
While this normalized signal size (i.e., fractional change in fluorescence) is the commonly
reported value in quantitative microscopy, the signal-to-noise ratio of this signal determines
how reliably it can be measured. To analyse the effect of indicator Ca2+-affinity on the SNR, we
make a number of assumptions:
1. The resting [Ca2+] is 50 nM.
2. The brightness of both indicators at maximal [Ca2+] is equal.
3. The detection system does not add additional noise sources.
4. The baseline fluorescence is calculated as the average of 50 time points.
As fluorescence is a stochastic quantum event, the measured intensity (i.e., number of
detected photons) will be determined by Poisson statistics (Pawley, 2006). In consequence,
the noise level of fluorescence is equal to the square root of the fluorescence intensity. To
estimate how this noise determines the uncertainty of the calculated dF/F0 values and
ultimately which SNR can be achieved at a given maximum brightness, we performed a Monte-
Carlo analysis: Random Poisson noise was added to the [Ca2+]-dependent fluorescence curves
shown in Appendix figure 1A, this was repeated 10,000 times. In addition a signal baseline
consisting of 50 points was generated by drawing samples from a Poisson distribution with
a mean of the fluorescence expected at resting [Ca2+]. For each iteration the dF/F0 ratio was
calculated. Finally the average dF/F0 curve as well as the corresponding standard deviation
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(SD) over all iterations were determined. As the brightness of the sample (i.e., fluorescence
intensity at maximal [Ca2+]) strongly influences the SNR, this analysis was initially performed at
a fixed maximum brightness of 1000 photons (e.g., the signal resulting from four detected
fluorescence photons per excitation pulse at a 3 μs pixel dwell time). While the resulting noise
appears negligible against the raw Ca2+ binding curve in Appendix figure 1A, the
propagated error following dF/F0 normalization is substantial (Appendix figure 1B) and the
resulting [Ca2+]-dependent SNR (SNR([Ca2+]) = Fluorescence([Ca2+])/SD([Ca2+])) curves clearly
show that as a consequence of the brighter baseline fluorescence the higher affinity CaRuby-
Nano is expected to always yield a better SNR than CaRuby-Me under the simulated
conditions. Under sufficiently bright conditions, such as those assumed in Appendix figure
1A–C, the much larger signal achievable at [Ca2+] over ∼400 nM outweighs this SNR
advantage.
To see how the balance between SNR and signal amplitude change with changing signal
brightness, we determined the SNR curves for varying levels of maximum brightness (from 10 to
10,000 photons; Appendix figure 1D,E). As expected we find that for a given indicator, the
dimmer the imaging conditions, the larger a [Ca2+] transient needs to be for reliable detection
(assumed to require SNR ≥ 2). On the other hand, the required [Ca2+] transient amplitude for
reliable detection at a given brightness strongly depends on the Ca2+ affinity of the indicator,
with higher affinity CaRuby-Nano requiring substantially smaller transients than CaRuby-Me
(Appendix figure 1F). What is a level of brightness that can be expected in biological imaging?
Tan et al. reported a photon-flux range of 1–4 photons per μs at rest when using Oregon–Green
488 BAPTA-1 (Tan et al., 1999) (OGB-1), which would correspond to approximately 3–12
photons at fully saturating [Ca2+]. Thus, even when summing the signal from dozens of pixels,
maximum brightness is expected to be in the range of 100–500 photons for standard pixel
dwell times (1–4 μs). At this brightness CaRuby-Me would require Ca2+ transients reaching ∼290
nM [Ca2+] to cross the SNR = 2 threshold (just below the level of the transients evoked by
Appendix 1 Figure 1. Signal amplitude and SNR depend on indicator KD. (A) [Ca
2+]-dependent fluorescence
for CaRuby-Me (blue) and CaRuby-Nano (red). The theoretical noise levels (1 SD) are indicated by the
translucent areas. (B) [Ca2+]-dependent dF/F0 for both indicators (same colors as in a) with the uncertainties
indicated by the areas surrounding the curves. (C) [Ca2+]-dependent SNR (same color code as in A). Note that
the noise on the curves is a consequence of the Monte-Carlo simulations. (D) SNR curves for CaRuby-Me at
different maximum fluorescence levels (maximal photon numbers indicated next to the corresponding curves).
The grey area marks the area with SNR < 2. (E) SNR curves for CaRuby-Nano at the same brightness levels as in
d. (F) [Ca2+]peak required to reach SNR = 2 for different maximal brightness levels.
DOI: 10.7554/eLife.05808.015
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a single action potential in CA1 pyramidal neurons [Maravall et al., 2000]) whereas CaRuby-
Nano would require transients under 100 nM.
Taken together these results show that while under bright conditions low-affinity indicators
have the advantage of larger signal amplitudes, under the dimmer conditions often found
in biological imaging, lower affinity dyes will often be working at the edge of the
detectability. Thus, for quantification of small, localized (i.e., where it is not possible to
average many pixels) Ca2+ signals, high affinity indicators such as OGB-1 and CaRuby-Nano
are needed.
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